期刊文献+

子宫内膜癌侵袭与转移的分子基础 被引量:1

下载PDF
导出
摘要 子宫内膜癌(endometrialcarcinoma,EC)为女性生殖器三大恶性肿瘤之一,高发年龄在58~61岁,发病率约占女性生殖器恶性肿瘤的50%,居女性全身恶性肿瘤第4位,近年来发病率略有上升趋势,病死率居女性全身恶性肿瘤第8位。随着医疗科学技术及分子生物学的发展,出现了基因治疗、分子靶向治疗等新的EC治疗方法。
作者 欧奇志
出处 《内科》 2013年第4期404-407,共4页 Internal Medicine
基金 广西壮族自治区卫生厅计划课题(合同号z2007045)
  • 相关文献

参考文献36

  • 1Ahmedin Jemal, Rebecca Siegel, Jiaquan Xu, et al. Cancer statistic 2010[ J]. CA Cancer J Clin,2010,60(5 ) :277 -300.
  • 2Zhu C, Luo J, Shi H, et al. Expression of tubulin,p53, ki67, receptors for estrogen, and progesterone in endometrial cancer [ J ]. Eur J Gynaecal Oncol,2009,30(5) :514 -517.
  • 3Amiaiuei C, Caruntu ID, Balan R, et al. Contribution of immunohisto- chemistry and flow-cytometry in the study of endometrial pathology [ J]. Rev Med Chir Soe Med Nat Iasi ,2008,112 (2) :437 -448.
  • 4Weigel MT, Kraaner J, Schem C, et al. Differential expression of MMP-2, MMP-9 and PCNA in endometriosis and endometrial carci- noma [ J ]. Eur J Obstet Gynecol Reprod Biol, 2012,160 ( 1 ) : 74 -78.
  • 5Tuveson DA, Shaw AT, Willis NA, et al. Endogenous oncogenic K-ras (G12D) stimulates proliferation and widespread neoplastic and de- velopmental defects [ J ]. Cancer Ce11,2004,5 (4) : 375 - 378.
  • 6黄小琪.子宫内膜癌与K-ras基因突变的研究[J].细胞与分子免疫学杂志,2010,26(7):701-702. 被引量:3
  • 7Hu K, Zhong G, He F. Expression of estrogen receptors ERalpha and ERbeta in endometrial hyperplasia and adenocarcinoma [ J ] . Int J Gynecol Cancer,2005,15 (3) :537 - 541.
  • 8欧奇志,张岩,于丽,祝诚,廖秦平.雌激素受体亚型α对子宫内膜癌细胞HEC-1B侵袭能力调控的研究[J].现代妇产科进展,2008,17(1):31-35. 被引量:1
  • 9Bircan S, Ensari A, Ozturk S, et al. Immunohistochemial Analysis of c-myc, c-Jun and Estrogen Receptor in Normal, Hyperplastic and Ne- oplastic Endometrium [ J ]. Pathol oncol. Res,2005,11 ( 1 ) :38.
  • 10齐卫红,鹿彩莲,孙显露.子宫内膜癌细胞核DNA含量及雌孕激素受体的研究[J].实用妇产科杂志,2000,16(3):151-152. 被引量:11

二级参考文献52

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2张岩,廖秦平,于丽,赵健,陈春玲.子宫内膜癌细胞雌激素受体亚型的调控和功能的初步研究[J].中华妇产科杂志,2005,40(8):558-561. 被引量:5
  • 3刘尚廉.乳腺癌雌激素受体的酶联雌二醇组化标记法[J].肿瘤,1986,6(3):104-106.
  • 4[1]Dong JT,Lamb PW,Rinker Schaeffer CW,et al.KAI1/CD82,a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2.Science,1995,268 (12):884
  • 5[2]Yang X,Wei L,Tang C.KAI1/CD82 expression is up -regulated during the progression of human breast cancer.Clin Cancer Res,2000,6 (9):3424
  • 6[3]Adachi M,Taki T,Huang C,et al.Reduced integrin alpha3 expression as a factor poor prognosis of patients with adenocarcinoma of the lung.J Clin Oncol,1998,16(12):1060
  • 7[4]Adachi M,Taki T,Icki Y,et al.Correlation of KAI1/CD82 gene expression with good prognosis in patients with nonsmall cell lung cancer.Cancer Res,1996,56 (8):1751
  • 8[5]Muenyuki T,Watanabe M,Yamanaka M,et al.KAI1/CD82 expression as aprognosic factor in sporadic colorectak cancer.Anticancer Res,2001,21 (5):3581
  • 9[6]Friess H,Guo XZ,Berberat P,et al.Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastasis.Int J Cancer,1998,79 (4):349
  • 10[7]Schindl M,Birner P,Breitenecker,et al.Downregulation of KAI1/CD82 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer.Gynecol Oncol,2001,83 (2):244

共引文献16

同被引文献14

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部